Axel Nierhaus (A Nierhaus)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Venues

International journal of molecular sciences

Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

University Medical Center Hamburg-Eppendorf

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Medical Center Hamburg-Eppendorf Jan 01 2004

Germany

Senior Consultant Intensivist :: Department of Intensive Care Medicine

Publications

Dominik Jarczak, Stefan Kluge, Axel Nierhaus
Septic Hyperinflammation-Is There a Role for Extracorporeal Blood Purification Techniques? International journal of molecular sciences 25 (6) (2024)
Dominik Jarczak, Stefan Kluge, Axel Nierhaus
Septic Hyperinflammation-Is There a Role for Extracorporeal Blood Purification Techniques? International journal of molecular sciences 25 (6) (2024)
Dominik Jarczak, Stefan Kluge, Axel Nierhaus
Septic Hyperinflammation-Is There a Role for Extracorporeal Blood Purification Techniques? International journal of molecular sciences 25 (6) (2024)
Steffen Mitzner, Klaus Kogelmann, Can Ince, Zsolt Molnár, Ricard Ferrer, Axel Nierhaus
Adjunctive Hemoadsorption Therapy with CytoSorb in Patients with Septic/Vasoplegic Shock: A Best Practice Consensus Statement. Journal of clinical medicine 12 (23) (2023)
Kevin Roedl, Dominik Jarczak, Olaf Boenisch, Geraldine de Heer, Christoph Burdelski, Daniel Frings, Barbara Sensen, Axel Nierhaus, Stefan Kluge, Dominic Wichmann
Chronic Critical Illness in Patients with COVID-19: Characteristics and Outcome of Prolonged Intensive Care Therapy. Journal of clinical medicine 11 (4) (2022)
Axel Nierhaus, Jesus Morales, Daniel Wendt, Jörg Scheier, Dominik Gutzler, Dominik Jarczak, Frank Born, Christian Hagl, Efthymios Deliargyris, Yatin Mehta
Comparison of the CytoSorb ® 300 mL and Jafron HA380 hemoadsorption devices: an in vitro study. Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy 31 (7) (2022)
Dominik Jarczak, Axel Nierhaus
Cytokine Storm-Definition, Causes, and Implications. International journal of molecular sciences 23 (19) (2022)
Kevin Roedl, Ahmel Kahn, Dominik Jarczak, Marlene Fischer, Olaf Boenisch, Geraldine de Heer, Christoph Burdelski, Daniel Frings, Barbara Sensen, Axel Nierhaus, Stephan Braune, Yalin Yildirim, Alexander Bernhardt, Hermann Reichenspurner, Stefan Kluge, Dominic Wichmann
Clinical Characteristics, Complications and Outcomes of Patients with Severe Acute Respiratory Distress Syndrome Related to COVID-19 or Influenza Requiring Extracorporeal Membrane Oxygenation-A Retrospective Cohort Study. Journal of clinical medicine 10 (22) (2021)
Kevin Roedl, Gerold Söffker, Dominic Wichmann, Olaf Boenisch, Geraldine de Heer, Christoph Burdelski, Daniel Frings, Barbara Sensen, Axel Nierhaus, Dirk Westermann, Stefan Kluge, Dominik Jarczak
Characteristics and Risk Factors for Intensive Care Unit Cardiac Arrest in Critically Ill Patients with COVID-19-A Retrospective Study. Journal of clinical medicine 10 (10) (2021)
Maria Schroeder, Berfin Schaumburg, Zacharias Mueller, Ann Parplys, Dominik Jarczak, Kevin Roedl, Axel Nierhaus, Geraldine de Heer, Joern Grensemann, Bettina Schneider, Fabian Stoll, Tian Bai, Henning Jacobsen, Martin Zickler, Stephanie Stanelle-Bertram, Kristin Klaetschke, Thomas Renné, Andreas Meinhardt, Jens Aberle, Jens Hiller, Sven Peine, Lothar Kreienbrock, Karin Klingel, Stefan Kluge, Guelsah Gabriel
High estradiol and low testosterone levels are associated with critical illness in male but not in female COVID-19 patients: a retrospective cohort study. Emerging microbes & infections 10 (1) (2021)
Kevin Roedl, Dominik Jarczak, Marlene Fischer, Munif Haddad, Olaf Boenisch, Geraldine de Heer, Christoph Burdelski, Daniel Frings, Barbara Sensen, Mahir Karakas, Stefan Kluge, Axel Nierhaus
MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 26 (5) (2021)
Thomas Theo Brehm, Andreas Heyer, Kevin Roedl, Dominik Jarczak, Axel Nierhaus, Michael F Nentwich, Marc van der Meirschen, Alexander Schultze, Martin Christner, Walter Fiedler, Nicolaus Kröger, Tobias B Huber, Hans Klose, Martina Sterneck, Sabine Jordan, Benno Kreuels, Stefan Schmiedel, Marylyn Martina Addo, Samuel Huber, Ansgar W Lohse, Stefan Kluge, Julian Schulze Zur Wiesch
Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020. Journal of clinical medicine 10 (11) (2021)
Axel Nierhaus, Giorgio Berlot, Detlef Kindgen-Milles, Eckhard Müller, Massimo Girardis
Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis. Annals of intensive care 10 (1) (2020)
Dominik Jarczak, Stefan Kluge, Axel Nierhaus
Use of Intravenous Immunoglobulins in Sepsis Therapy-A Clinical View. International journal of molecular sciences 21 (15) (2020)
Mahir Karakas, Dominik Jarczak, Martin Becker, Kevin Roedl, Marylyn M Addo, Frauke Hein, Andreas Bergmann, Jens Zimmermann, Tim-Philipp Simon, Gernot Marx, Marc Lütgehetmann, Axel Nierhaus, Stefan Kluge
Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101). Biomolecules 10 (8) (2020)
Axel Nierhaus, J Linssen, M S Winkler, D P Frings, S Kluge
The Effects of Ex Vivo Administration of Granulocyte-Macrophage Colony-Stimulating Factor and Endotoxin on Cytokine Release of Whole Blood Are Determined by Priming Conditions. BioMed research international 2017 (2017)

Axel Nierhaus.css-eqlu8i{font-size:small;padding-left:4px;} (A Nierhaus)

Publication Activity (10 Years)

Top Topics

Top Venues

Axel Nierhaus (A Nierhaus)